Products
Data
Feature
Plans
Request Demo
Featured News
news cover
Rapport Therapeutics Announces New Data and Post Hoc Analysis Demonstrating the Magnitude and Consistency of RAP-219’s Clinical Response in Patients with Focal Onset Seizures
21 hours ago
news cover
Prime Medicine Announces The New England Journal of Medicine Publication of PM359 Clinical Data for the Treatment of Chronic Granulomatous Disease
11 hours ago
news cover
Secura Bio Presents Extended Follow Up Analyses from Phase 2 PRIMO Trial in Patients with Relapsed/Refractory peripheral T-cell lymphoma at the 2025 American Society of Hematology Meeting
11 hours ago
news cover
Ajax Therapeutics Presents Preclinical Data on Differentiated Efficacy Profile of AJ1-11095, a First-in-Class Type II JAK2 Inhibitor, at the American Society of Hematology Annual Meeting
12 hours ago
Latest
R&D
Deals
Investment
Policy
Perspective
View more
Global Express
4 hours ago
Cereno Scientific Receives FDA Clearance to Initiate Global Phase IIb Trial of CS1 in Pulmonary Arterial Hypertension (PAH)
Phase 2Fast TrackOrphan DrugClinical ResultPhase 1
6 hours ago
Copper Roots Family Care Now Offering Shockwave Therapy for Faster Recovery and Pain Relief
6 hours ago
Hemab Therapeutics Announces Positive Complete Phase 2 Data for Sutacimig in Glanzmann Thrombasthenia at ASH 2025; Plans to Advance to Pivotal Phase 3 Study
Clinical ResultPhase 2Fast TrackOrphan DrugASH
7 hours ago
Tiger BioSciences Highlights Study on Advanced Placental CAMP Technologies
7 hours ago
Axis Integrated Mental Health Partners with Propagate Hope Counseling to Reach 266K Coloradans at Risk of Suicide
View more
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Hot reports
May 2025 Patent  Highlights
May 2025 Patent Highlights
Patsnap Synapse
JMC Annotation Spotlight: Analysis of Breakthrough Therapeutics
JMC Annotation Spotlight: Analysis of Breakthrough Therapeutics
Patsnap Synapse
Global Drug R&D Express (February 2025)
Global Drug R&D Express (February 2025)
PatSnap Synapse
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.

Who we are

  • Solutions
  • Plan
  • Contact us: phs@patsnap.com

What we do

  • Drug
  • Clinical Progress
  • Patent
  • Literature
  • Report
  • News

Keep updated

Try Synapse

PatSnap group products

© 2023 PatSnap. All rights reserved. Legal | Privacy Policy | Modern Slavery Act Transparency Statement | Manage Cookies